
Professor
Stephen Proctor
|
The Scotland
& Newcastle Lymphoma Group (SNLG) was first founded in 1979
when groups of doctors from Newcastle and the Northern Region met
with those from Edinburgh, Dundee and Aberdeen to decide to collaborate
and co-operate in the investigation and treatment of people with
lymph-gland cancers. During the course of the 1980s the west
of Scotland joined the group and at the present time the collective
organisation has the largest, most comprehensive (anonymised) dataset
on lymph-gland cancer worldwide.
|
|
1200 new patients present with this form of tumour annually and
it is one of the most diverse forms of disease area within medicine.
There are 24 to 30 different microscopic categories and the disease
affects different organs at different times of life. Progress for
many of the areas is hampered because of the sheer diversity of
the problem. Because of the logically, co-ordinated approach that
has been in place now for over 20 years, the SNLG has been able
to use its experience and data to bring rational and developmental
treatments to a whole range of the sub-groups. This last year has
seen the organisation, to a large extent funded by Marrow Transplant
2000, NEPAC and other charities, produce a series of ground-breaking
publications which have changed the treatments for many of these
patients and we hope will benefit many more worldwide. As you can
see this is a long-term, painstaking business.
In previous years I have demonstrated big strides for Hodgkins
disease but progress with non-Hodgkins lymphoma is much slower.
This is a form of tumour which has been increasing in incidence
by 4% per annum since 1980. The plan for the immediate future is
to further enhance the clinico-laboratory based research area of
non-Hodgkins lymphoma.
|